SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending following positive topline results from its Phase I/II study of AMT-130 for Huntington's Disease, with community members discussing the potential for FDA traditional approval. The news has sparked significant pre-market gains, and investors are weighing potential entry points and price targets. Community members are also evaluating financial overviews of the company.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending following an upgrade from Wells Fargo, citing expected AWS growth driven by AI initiatives, with a price target increase to $280. However, some traders express frustration with AMZN's YTD performance and question its ability to keep pace with other tech giants, while others are looking ahead to a potential catalyst at the upcoming hardware event on September 30th.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas ($LAC) is trending amid speculation that the Trump administration is considering taking an equity stake in the company. Community members are discussing potential short squeezes due to low float and high short interest, with some setting price targets. The potential government stake is seen as a bullish signal for the company's Thacker Pass lithium mine and the broader domestic lithium supply chain.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending due to strong earnings and positive guidance, fueled by surging demand for memory in AI applications. The community is closely watching the stock's reaction, with many anticipating further gains and upgrades based on the company's leadership in HBM technology. Some traders are cautious, citing the stock's recent run-up and potential for profit-taking, while others see significant long-term upside amid tight supply conditions.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending due to a recent downgrade from Jefferies, sparking debate about the company's valuation and future growth prospects. While some investors see the drop as a buying opportunity, citing previous positive analyst ratings and the company's fundamentals, others are concerned about unclear growth beyond 2026 and potential overvaluation. The community is actively discussing the impact of analyst ratings and the possibility of a coordinated effort to suppress the stock price.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending due to increased volume and community speculation about potential catalysts, including a possible buyout, upcoming presentations, and the Delaware court case. Community members are discussing insider buying, institutional ownership, and the potential impact of warrants expiring in January 2026. Some are expressing frustration with management and debating whether the stock is undervalued or a value trap.

Aqua Metals, Inc. engages in reinventing metal recycling technologies. Its patented technology, AquaRefining, replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover valuable metals and materials from spent batteries with higher purity, lower emissions, and minimal waste. The company was founded by Stephen R. Clarke, Thomas Murphy, and Selwyn Mould on June 20, 2014 and is headquartered in Reno, NV.

Aqua Metals Inc

Aqua Metals ($AQMS) is trending amid discussions of its potential in the lithium battery recycling sector, with the community highlighting its tiny float and potential for a squeeze. Bullish sentiment seems to be driven by insiders loading, sympathy plays with related stocks like $LAC and $XPON, and the broader narrative of a hot lithium sector. Some investors are also looking at news and government funding as catalysts for potential growth.

SHF Holdings, Inc. engages in the provision of financial services focused on the cannabis industry. It provides access to banking and financing solutions for the cannabis industry. The company was founded in July 2021 and is headquartered in Golden, CO.

SHF Holdings Inc - Ordinary Shares - Class A

SHF Holdings Inc

SHF Holdings is trending due to a recently announced $150 million common stock purchase agreement, sparking discussions around potential dilution and the company's financial health. The community is actively debating whether this news will lead to a pump and dump scenario or a sustained upward trend. Some traders are focusing on the stock's low float and potential for volatility, drawing comparisons to other high-flying stocks.

iQSTEL, Inc. operates as a technology company, which engages in the provision of technology and telecommunications services. It offers long-distance voice services for telecom carriers and submarine fiber optic network capacity for data carriers and internet service providers both land-based and mobile. It operates through the USA and Switzerland geographical segments. The company was founded on June 28, 2008 and is headquartered in Coral Gables, FL.

iQSTEL Inc

IQST is trending amid discussions around its recent milestones, including its 120th day on the Nasdaq and strategic alliances like the one with Cycurion, which involves a stock exchange and potential dividend distribution. While some shareholders express frustration with the stock's performance and management, others highlight institutional investment and the company's revenue targets. Community members are also closely watching the progress of the Cycurion dividend and the potential for future growth in the AI and fintech sectors.

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

ClearPoint Neuro Inc

ClearPoint Neuro (CLPT) is trending following positive data related to partner uniQure's Huntington's disease program, as CLPT provides the neuro-navigation system for precise therapy delivery.  The community is discussing the potential revenue impact from increased adoption of CLPT's technology in conjunction with promising gene therapy developments.  Broader conversations include the growth potential of neuro-therapies and capital inflows into the bioscience sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analyzing Better Therapeutics (NASDAQ:BTTX) and Agape ATP (NASDAQ:ATPC)

Agape ATP (NASDAQ:ATPC  Get Free Report) and Better Therapeutics (NASDAQ:BTTX  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare...

12 titoli sanitari in movimento, pre-market del 15/03/2024

Titoli in rialzo
Le azioni di Better Therapeutics (NASDAQ:BTTX) hanno guadagnato il 69,14% a 0,06 dollari durante la sessione pre-market di venerd .
Le azioni di Madrigal Pharmaceuticals...

12 acciones de salud en movimiento durante la preapertura del 15/03/2024

Acciones al alza
Better Therapeutics (NASDAQ:BTTX) ganaron un 77,14% para establecerse en los 0,06 d lares durante la sesi n del pre-market del viernes.
Madrigal Pharmaceuticals (NASDAQ:MDGL...

Better Therapeutics trading resumes

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Better Therapeutics, Inc. (NASDAQ: BTTX) (the Company) announced today that the Company is terminating its employees and will explore strategic alternatives, including assignment for the benefit of...

Better Therapeutics trading halted, news pending

Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced a major partnership with the American...

Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced the acceptance of a late-breaking...

Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. (Nasdaq:BTTX) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big...

Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that the U.S. Food and Drug...

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.

Better Therapeutics Inc

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

BTTX
Better Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BTTX News

BTTX Better Therapeutics Inc